{"id":3592,"date":"2025-04-17T06:42:30","date_gmt":"2025-04-17T06:42:30","guid":{"rendered":"https:\/\/visionranking.com\/wegovita\/?page_id=3592"},"modified":"2025-04-17T07:03:31","modified_gmt":"2025-04-17T07:03:31","slug":"individual-standard-medical-plan-for-dendritic-cell-therapy-in-advanced-melanomaadd-melanoma-in-advanced-cancer","status":"publish","type":"page","link":"https:\/\/visionranking.com\/wegovita\/individual-standard-medical-plan-for-dendritic-cell-therapy-in-advanced-melanomaadd-melanoma-in-advanced-cancer\/","title":{"rendered":"Individual Standard Medical Plan for Dendritic Cell Therapy in Advanced Melanoma(add Melanoma in advanced cancer)"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"3592\" class=\"elementor elementor-3592\">\n\t\t\t\t\r\n<div class=\"elementor-element elementor-element-33eb9883 e-con-full e-flex e-con e-parent\" data-id=\"33eb9883\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t<div class=\"elementor-element elementor-element-53886e3b e-con-full e-flex e-con e-child\" data-id=\"53886e3b\" data-element_type=\"container\">\n\t\t\r\n\t\t<div class=\"elementor-element elementor-element-12a52fc4 elementor-widget elementor-widget-mediaxbutton\" data-id=\"12a52fc4\" data-element_type=\"widget\" data-widget_type=\"mediaxbutton.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"btn-wrapper\"><a class=\"th-btn th_btn \" href=\"https:\/\/visionranking.com\/wegovita\/treatments\/\">All Treatments Services<\/a><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-43bfaaa e-con-full e-flex e-con e-child\" data-id=\"43bfaaa\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1e8c7b94 elementor-widget elementor-widget-mediaxbutton\" data-id=\"1e8c7b94\" data-element_type=\"widget\" data-widget_type=\"mediaxbutton.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"btn-wrapper\"><a class=\"th-btn th_btn \" href=\"https:\/\/visionranking.com\/wegovita\/contact-us\/\">Contact Us<\/a><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-3cb4a742 e-flex e-con-boxed e-con e-parent\" data-id=\"3cb4a742\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-164333cf e-con-full e-flex e-con e-child\" data-id=\"164333cf\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1eabf745 elementor-widget elementor-widget-image\" data-id=\"1eabf745\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-3-300x300-1.png\" class=\"attachment-large size-large wp-image-3610\" alt=\"\" srcset=\"https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-3-300x300-1.png 300w, https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-3-300x300-1-150x150.png 150w, https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-3-300x300-1-85x85.png 85w, https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-3-300x300-1-100x100.png 100w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-76b7b684 e-con-full e-flex e-con e-child\" data-id=\"76b7b684\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-47f414e2 elementor-widget elementor-widget-image\" data-id=\"47f414e2\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-2-2.png\" class=\"attachment-large size-large wp-image-3611\" alt=\"\" srcset=\"https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-2-2.png 500w, https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-2-2-300x300.png 300w, https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-2-2-150x150.png 150w, https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-2-2-85x85.png 85w, https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-2-2-100x100.png 100w\" sizes=\"(max-width: 500px) 100vw, 500px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-127672b1 e-con-full e-flex e-con e-child\" data-id=\"127672b1\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-670811be elementor-widget elementor-widget-image\" data-id=\"670811be\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-1-300x300-1.png\" class=\"attachment-large size-large wp-image-3612\" alt=\"\" srcset=\"https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-1-300x300-1.png 300w, https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-1-300x300-1-150x150.png 150w, https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-1-300x300-1-85x85.png 85w, https:\/\/visionranking.com\/wegovita\/wp-content\/uploads\/2025\/04\/Individual-Standard-Medical-Plan-for-Dendritic-Cell-Therapy-in-Advanced-Melanoma-1-300x300-1-100x100.png 100w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-5912e2a5 e-flex e-con-boxed e-con e-parent\" data-id=\"5912e2a5\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-363a8d8 elementor-widget elementor-widget-text-editor\" data-id=\"363a8d8\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h4>Dendritic Cell Therapy for Advanced Melanoma<\/h4><div class=\"section\"><h5>1. Staging of Advanced Melanoma<\/h5><p>Melanoma staging is crucial for determining the appropriate treatment strategy, including the feasibility of dendritic cell therapy. Staging is based on the AJCC (American Joint Committee on Cancer) TNM system:<\/p><ul><li><strong>Stage III:<\/strong>\u00a0Regional lymph node involvement without distant metastasis.<\/li><li><strong>Stage IV:<\/strong>\u00a0Presence of distant metastases in organs such as the lungs, liver, brain, or distant skin sites.<\/li><\/ul><p>Dendritic cell therapy is primarily considered for Stage III and IV melanoma patients who are not responding to conventional treatments or seeking personalized immunotherapy approaches.<\/p><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-9b85635 e-flex e-con-boxed e-con e-parent\" data-id=\"9b85635\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-bc379f5 elementor-widget elementor-widget-text-editor\" data-id=\"bc379f5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5>2. Initial Consultation and Patient Assessment<\/h5><ul><li><strong>Comprehensive oncological evaluation:<\/strong>\u00a0Includes a thorough medical history, physical examination, and assessment of disease progression.<\/li><li><strong>Imaging studies:<\/strong>\u00a0MRI, CT, or PET scans to confirm tumor burden and metastatic spread.<\/li><li><strong>Histopathological confirmation:<\/strong>\u00a0Biopsy with immunohistochemical analysis to identify melanoma-specific markers.<\/li><li><strong>Immune profiling:<\/strong>\u00a0Blood tests to evaluate immune system status, including lymphocyte subsets, cytokine levels, and tumor antigen expression.<\/li><li><strong>Biomarker testing:<\/strong>\u00a0Assessment of BRAF, NRAS, and c-KIT mutations, as targeted therapies may complement dendritic cell therapy.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-7db5569 e-flex e-con-boxed e-con e-parent\" data-id=\"7db5569\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b16c68b elementor-widget elementor-widget-text-editor\" data-id=\"b16c68b\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5>3. Leukapheresis (White Blood Cell Collection)<\/h5><ul><li><strong>Procedure:<\/strong>\u00a0Peripheral blood is drawn, and mononuclear cells (including dendritic cell precursors) are isolated through leukapheresis.<\/li><li><strong>Duration:<\/strong>\u00a03-4 hours in a sterile, controlled environment.<\/li><li><strong>Safety measures:<\/strong>\u00a0Patients are monitored for potential side effects, including transient hypotension or hypocalcemia.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6b5925a e-flex e-con-boxed e-con e-parent\" data-id=\"6b5925a\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-45a7af0 elementor-widget elementor-widget-text-editor\" data-id=\"45a7af0\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5>4. Dendritic Cell Cultivation and Tumor Antigen Loading<\/h5><ul><li><strong>Cell maturation:<\/strong>\u00a0Isolated dendritic cell precursors are cultured in vitro and differentiated into mature antigen-presenting cells using cytokine stimulation (e.g., GM-CSF, IL-4, TNF-\u03b1).<\/li><li><strong>Tumor antigen loading:<\/strong>\u00a0Dendritic cells are exposed to melanoma-associated antigens (e.g., gp100, tyrosinase, MAGE-A3, NY-ESO-1) to induce a tumor-specific immune response.<\/li><li><strong>Timeframe:<\/strong>\u00a07-10 days to ensure proper antigen processing and expression.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-59b2a07 e-flex e-con-boxed e-con e-parent\" data-id=\"59b2a07\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d09b175 elementor-widget elementor-widget-text-editor\" data-id=\"d09b175\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5>5. Quality Control and Activation Testing<\/h5><ul><li><strong>Viability assessment:<\/strong>\u00a0Dendritic cell cultures undergo quality control to ensure high viability and functionality.<\/li><li><strong>Phenotypic analysis:<\/strong>\u00a0Flow cytometry is used to confirm the expression of key activation markers (CD80, CD86, MHC class I and II).<\/li><li><strong>Cytokine secretion profile:<\/strong>\u00a0ELISA or multiplex assays verify the ability of dendritic cells to produce IL-12 and other immune-stimulating cytokines.<\/li><li><strong>Sterility testing:<\/strong>\u00a0Ensures the absence of bacterial, fungal, or endotoxin contamination before administration.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-678527f e-flex e-con-boxed e-con e-parent\" data-id=\"678527f\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0785ba5 elementor-widget elementor-widget-text-editor\" data-id=\"0785ba5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5>6. Intradermal or Intravenous Administration<\/h5><ul><li><strong>Mode of administration:<\/strong>\u00a0Intradermal injections (commonly at multiple sites) or intravenous infusion depending on the clinical protocol.<\/li><li><strong>Treatment cycles:<\/strong>\u00a0Generally, three to six doses administered at two-week intervals.<\/li><li><strong>Adjuvant combinations:<\/strong>\u00a0Can be administered alongside checkpoint inhibitors (e.g., anti-PD-1\/PD-L1 such as pembrolizumab or nivolumab) for enhanced therapeutic efficacy.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-da614ef e-flex e-con-boxed e-con e-parent\" data-id=\"da614ef\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-ef76932 elementor-widget elementor-widget-text-editor\" data-id=\"ef76932\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5>7. Immune Response Monitoring and Follow-Up<\/h5><ul><li><strong>Regular follow-up visits:<\/strong>\u00a0Every 3-6 months for clinical assessment and disease monitoring.<\/li><li><strong>Blood tests:<\/strong><\/li><li>T-cell activation assays to measure tumor-specific cytotoxic T-lymphocyte (CTL) responses.<\/li><li>Monitoring of melanoma tumor markers (e.g., S100, LDH levels).<\/li><li><strong>Imaging studies:<\/strong>\u00a0Routine MRI, CT, or PET scans to evaluate tumor response and progression.<\/li><li><strong>Booster doses:<\/strong>\u00a0Additional dendritic cell vaccine administrations may be considered if immune response declines or disease progression is noted.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-d3949bb e-flex e-con-boxed e-con e-parent\" data-id=\"d3949bb\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-87958b0 elementor-widget elementor-widget-text-editor\" data-id=\"87958b0\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5>8. Integrative and Supportive Therapies<\/h5><ul><li><strong>Checkpoint inhibitors:<\/strong>\u00a0Anti-PD-1\/PD-L1 monoclonal antibodies may be combined to improve T-cell-mediated anti-tumor response.<\/li><li><strong>Cytokine therapy:<\/strong>\u00a0Administration of IL-2 or IFN-\u03b1 may be considered to further enhance immune activation.<\/li><li><strong>Nutritional support:<\/strong>\u00a0Personalized dietary recommendations to optimize immune function and minimize treatment-related fatigue.<\/li><li><strong>Psychological support:<\/strong>\u00a0Oncology counseling and rehabilitation programs to improve the patient\u2019s mental well-being and quality of life.<\/li><li><strong>Lifestyle modifications:<\/strong>\u00a0Physical activity, stress reduction techniques, and smoking cessation to enhance overall health and treatment outcomes.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6ac2bd9 e-flex e-con-boxed e-con e-parent\" data-id=\"6ac2bd9\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-161d98b elementor-widget elementor-widget-text-editor\" data-id=\"161d98b\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3>Conclusion<\/h3><p><strong>Dendritic cell therapy<\/strong>\u00a0offers a promising immunotherapeutic approach for advanced melanoma patients, particularly in cases where conventional therapies have failed or are not well tolerated. This individualized medical plan ensures a comprehensive, evidence-based approach, maximizing therapeutic efficacy while integrating supportive strategies for optimal patient care.<\/p><p><strong>Send us your reports if you or a relative has melanoma disease for an individualized medical study and a specific treatment plan with prognosis. You can receive a fast evaluation within 48 hours and start your treatment in 3 to 4 weeks. Our back office coordinates fast and urgent appointments for our international patients, ensuring timely access to advanced cancer treatment.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-efa1e35 e-flex e-con-boxed e-con e-parent\" data-id=\"efa1e35\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b649f19 elementor-widget elementor-widget-text-editor\" data-id=\"b649f19\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"contact\"><h2 style=\"text-align: center;\">\ud83d\udce9<\/h2><h5 style=\"text-align: center;\">Request Now \u2013 Receive expert evaluation from top German doctors in 48 hours and start your treatment journey in just 3 weeks!<\/h5><\/div><div class=\"video\" style=\"text-align: center;\">\u00a0<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-13eee09 elementor-widget elementor-widget-mediaxbutton\" data-id=\"13eee09\" data-element_type=\"widget\" data-widget_type=\"mediaxbutton.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"btn-wrapper\"><a class=\"th-btn th_btn \" href=\"https:\/\/visionranking.com\/wegovita\/contact-us\/\">Contact Us<\/a><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>All Treatments Services Contact Us Dendritic Cell Therapy for Advanced Melanoma 1. Staging of Advanced Melanoma Melanoma staging is crucial for determining the appropriate treatment strategy, including the feasibility of dendritic cell therapy. Staging is based on the AJCC (American Joint Committee on Cancer) TNM system: Stage III:\u00a0Regional lymph node involvement without distant metastasis. Stage&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3592","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/pages\/3592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/comments?post=3592"}],"version-history":[{"count":25,"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/pages\/3592\/revisions"}],"predecessor-version":[{"id":3625,"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/pages\/3592\/revisions\/3625"}],"wp:attachment":[{"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/media?parent=3592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}